Wedoany.com Report-Nov. 10, Bayer CropScience Limited, traded on the Bombay Stock Exchange under the code 506285, has disclosed its unaudited financial outcomes for the second quarter and the initial six months concluded on September 30, 2025.

In the second quarter ending September 30, 2025, the company achieved Revenue from Operations amounting to ₹15,534 million. This figure represents a comparison to ₹17,382 million recorded during the equivalent timeframe in the prior financial year, 2024-25. The Profit Before Tax for this period reached ₹2,003 million, showing an increase from ₹1,901 million in the corresponding quarter of the previous year.

For the first half of the year, wrapping up on September 30, 2025, Bayer CropScience Limited posted Revenue from Operations of ₹34,680 million. This is set against ₹33,696 million for the same interval in the 2024-25 financial year. The Profit Before Tax during this half-year period amounted to ₹5,355 million, up from ₹5,059 million in the parallel period of the preceding year.

Reflecting on the results for the quarter, Simon Wiebusch, who serves as Vice Chairman, Managing Director, and Chief Executive Officer of Bayer CropScience Limited, stated: ″Unusually prolonged and excessive rainfall impacted our field activities and product placement, resulting in significantly lower revenue from our Crop Protection portfolio. Despite this, our corn seed business continued its growth momentum, driven by competitive hybrids, strong execution, and favorable market dynamics. This quarter’s performance underscores our resilience and adaptability in the face of external challenges. We remain focused on preparedness and disciplined execution as we head into the Rabi season.″

Adding further insights, Vinit Jindal, the Executive Director and Chief Financial Officer at Bayer CropScience Limited, remarked: ″The Company delivered a solid performance with Profit After Tax up 12% in Q2 and 10% in H1 year-over-year. This was driven by a favorable sales mix, stabilized input costs, lower provisioning for doubtful receivables, and disciplined cost management.″

The company's Board of Directors, during their assembly on November 7, 2025, approved an interim dividend payout of ₹90 per equity share for the financial year concluding on March 31, 2026. This decision translates to a total distribution of ₹4,045 million.

These financial disclosures highlight the organization's operational performance amid varying conditions. The revenue figures for the quarter indicate adjustments due to external factors, while the profit metrics demonstrate improvements through internal strategies. The half-year results similarly reflect steady progress in key areas.

Bayer CropScience Limited continues to navigate its business segments, including crop protection and seed operations, with an emphasis on maintaining stability. The comments from leadership emphasize the role of adaptability in addressing challenges, such as weather-related disruptions, without compromising on long-term objectives.

The dividend declaration underscores the company's commitment to shareholder returns, based on the achieved results. Overall, the reported numbers provide a balanced view of the period's achievements, with comparisons to the previous year offering context for evaluation.

In summary, the unaudited results for the quarter and half-year ended September 30, 2025, showcase Bayer CropScience Limited's ability to sustain profitability despite fluctuations in revenue. The leadership's focus on execution and preparedness positions the company for upcoming seasons, ensuring continued emphasis on core business strengths.